News

Published on 5 Nov 2023 on Insider Monkey via Yahoo Finance

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript


Article preview image

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript November 3, 2023

Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Melanie Solomon, Investor Relations. Please go ahead.

Melanie Solomon: Thanks, Kevin. Good morning and welcome to the Fulgent third quarter 2023 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer. The company's press release discussing the financial results is available on the Invest Relations section of the company's website, www.fulgent.com. A replay of this call will be available shortly after the call concludes on the Investor Relations section of the company's website. Management’s prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward-looking statements represent management’s estimates based on current views and assumptions, which may prove to be incorrect.

NASDAQ.FLGT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript May 3, 2024 Fulgent Genetic...

Insider Monkey via Yahoo Finance 5 May 2024

Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates

Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.01 per share versus the Zacks ...

Zacks via Yahoo Finance 3 May 2024

An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued

Key Insights The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash...

Simply Wall St. via Yahoo Finance 1 Mar 2024

Earnings call: Fulgent Genetics posts $70 million Q4 revenue

Fulgent Genetics (NASDAQ: NASDAQ: FLGT ) has reported a total revenue of $70 million for the four...

Investing.com 29 Feb 2024

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript February 28, 2024 Fulgent G...

Insider Monkey via Yahoo Finance 29 Feb 2024

Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023

Total Revenue: $289.2 million for the full year; $70.5 million for Q4 2023.Core Revenue Growth: U...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Privia Health (PRVA) Misses Q4 Earnings Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Conse...

Zacks via Yahoo Finance 27 Feb 2024

Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results

Fulgent Genetics Inc (NASDAQ:FLGT) reports Q3 2023 total revenue of $85 million, with core revenu...

GuruFocus.com via Yahoo Finance 6 Nov 2023

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: ...

Insider Monkey via Yahoo Finance 5 Nov 2023

Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates

Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.39 per share versus the Zacks ...

Zacks via Yahoo Finance 3 Nov 2023